An Antibacterial Nanorobotic Approach for the Specific Targeting and Removal of Multiple Drug-Resistant Staphylococcus aureus
Nayab Batool, Seokyoung Yoon, Saba Imdad, Minsuk Kong, Hun Kim, Sangryeol Ryu, Jung Heon Lee, Akhilesh Kumar Chaurasia, and Kyeong Kyu Kim
Institute of Microbiology, University of Agriculture, Faisalabad 38000, Pakistan
Department of Precision Medicine Institute for Antimicrobial Resistance Research and Therapeutics Graduate School of Basic Medical Sciences (GSBMS)Sungkyunkwan University School of Medicine Suwon 16419, South Korea
School of Advanced Materials Science and Engineering, Sungkyunkwan University, Suwon 16419, South Korea
Department of Food Science and Technology Seoul National University of Science and Technology Seoul 01811, South Korea
Department of Food and Animal Biotechnology, Department of Agricultural Biotechnology, Research Institute of Agriculture and Life Sciences, Seoul National University
Methicillin-resistant Staphylococcus aureus (MRSA) causes diseases ranging from skin infections to lethal sepsis and has become a serious threat to human health due to multiple-drug resistance (MDR). Therefore, a resistance-free anti-bacterial therapy is necessary to overcome MDR MRSA infections. In this study, an antibacterial nanorobot (Ab-nanobot) is developed wherein a cell wall-binding domain (CBD)-endolysin, acting as a sensor, is covalently conjugated with an actuator consisting of an iron oxide/silica core–shell. The CBD-endolysin sensor shows an excellent specificity to detect, bind, and accumulate on the S. aureusUSA300 cell surface even in a bacterial consortium, and in host cell infections. Ab-nanobot specifically captures and kills MRSA in response to medically approved radiofrequency (RF) electromagnetic stimulation (EMS) signal. When Ab-nanobot receives the RF-EMS signal on the cell surface, actuator induces cell death in MRSA with 99.999% removal within 20 min by cell-wall damage via generation of localized heat and reactive oxygen species. The in vivo efficacy of Ab-nanobot is proven using a mice subcutaneous skin infection model. Collectively, this study offers a nanomedical resistance-free strategy to overcome MDR MRSA infections by providing a highly specific nanorobot for S. aureus.